{"name":"Britannia Pharmaceuticals Ltd.","slug":"britannia-pharmaceuticals-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Apomorphine Nasal Powder","genericName":"Apomorphine Nasal Powder","slug":"apomorphine-nasal-powder","indication":"Treatment of 'off' episodes in advanced Parkinson's disease","status":"phase_2"}]}],"pipeline":[{"name":"Apomorphine Nasal Powder","genericName":"Apomorphine Nasal Powder","slug":"apomorphine-nasal-powder","phase":"phase_2","mechanism":"Apomorphine works by stimulating dopamine receptors in the brain, which helps to improve motor function in people with Parkinson's disease.","indications":["Treatment of 'off' episodes in advanced Parkinson's disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxNcnZpNF8tTkEwUUUtbVA1eFpHdEhHVFVWSWh0YnlUa1F5dWxCdWNZcXJJNjFabEwwZk53M1FMOTJZUFNZRXVwd1c2blZqVWZ3UmUxc1ExOWg0M2VXNXBIbHBsOVpGQkdEbzdqYTRWbzF2al9kMXZ0QjlZRDVjMTlRR2Y2M2x1MnBtVXFnSEdLWU1uOGRfdmh2dWlMZDU1QUJLOHpmLUphRFM2RFNMRHV0SlppUWxsUHI4QlZBXzlud1dpbTlUWG5XSFM2QS00S0kyNUVhMmFVZURSbGRURTJlYW1uVkc5Q3JIYmFzd1Q1XzhRb0hxODFZYldVXzVveDVlb0J3R1ZRR1czWENsRTJYZG9MYmhwN1k?oc=5","date":"2026-01-19","type":"pipeline","source":"PR Newswire UK","summary":"Underactive Bladder Syndrome Market to Observe Stunning Growth at a CAGR of 22.1% During the Forecast Period (2025-2034) | DelveInsight - PR Newswire UK","headline":"Underactive Bladder Syndrome Market to Observe Stunning Growth at a CAGR of 22.1% During the Forecast Period (2025-2034)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxPWHhKcUs0Qzk1Z0dTdS1JNXRfcEg2cU1BTlBPM0xRa0V4dmxqUExKbVVXWFUwbXVpUnZHZXdjR3dkLW9la25JTWNkQ1RxUDZfR1BKbmpVa0ZVLVduV0NYcUlJbEdvdHR2aHF5NUI2ckhFb1FYVFNva1NYT190elBhbDBNVTgzcWpKVWRiVENQMUd2NjZrbmotRDJSVlJ6b2ZETGc5cURnV1BxSE9WOG51Y0Q0d25XZC1ELURFalZvZDJoejUwV1BYQldfeFJSLVpqdWVTYmd3blFaUVFvOW9mcFhYa1QyX2VoNENjMkl2dFktQUVnUEE?oc=5","date":"2025-11-11","type":"deal","source":"Zee Business","summary":"7 Stocks To Buy For Long Term: Analysts recommend 5 largecap and 2 midcap scrips; Trent, Britannia on the list - Zee Business","headline":"7 Stocks To Buy For Long Term: Analysts recommend 5 largecap and 2 midcap scrips; Trent, Britannia on the list","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-05","type":"earnings","source":"Mint","summary":"Q2 results today: Sun Pharma, Grasim Ind, Britannia among companies to declare earnings on Wednesday — 5 Nov 2025 - Mint","headline":"Q2 results today: Sun Pharma, Grasim Ind, Britannia among companies to declare earnings on Wednesday — 5 Nov 2025","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-05","type":"earnings","source":"NDTV Profit","summary":"Aurobindo, Sun Pharma, Blue Star, Britannia, Delhivery Q2 Results Today — Earnings Estimates - NDTV Profit","headline":"Aurobindo, Sun Pharma, Blue Star, Britannia, Delhivery Q2 Results Today — Earnings Estimates","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-05","type":"earnings","source":"Business Standard","summary":"Q2 results today: Britannia, Inox, Zydus Wellness among 118 firms - Business Standard","headline":"Q2 results today: Britannia, Inox, Zydus Wellness among 118 firms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxOS2d4WXpjcDB1bXVyOWJCaXloWlV4aGJ4SDFZRl9XSllDdWpXVkhac2V5R3JDcG1rOGZnb01MTU5JX2JPQTlCRDdsaTJOSnNRRlNFczkwV29JeW1zdnVoNW9KMUZjR3ZILWNmTkhIYVMtWE5xeURFck5CWEZGT0stM0FLSHhsRWh3TmxaN1VFTmFuTGMzbnk4SFJqdjY0V08tNVhOSGhpQl82WHk2VEE1WmFTN0lrQjVOQWtfOFdDV2VORzB3UTlNZmJJWHZMN2VLWmZRYWNXRm1jbVBsLVNMRjZRaUI1b3VCMFhncnZzSTBMQmotQTNMbE1KMGFhM1E?oc=5","date":"2025-11-04","type":"earnings","source":"upstox.com","summary":"Q2 Results: Sun Pharma, Grasim, Britannia, Blue Star, Astral, Delhivery, others to post earnings on Nov 5; check list - upstox.com","headline":"Q2 Results: Sun Pharma, Grasim, Britannia, Blue Star, Astral, Delhivery, others to post earnings on Nov 5; check list","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxORV9rNzJNLWJ2WWxXTktiM05GaUE3a3k2Z3dub2hlREZWUGdvVDBNT05Xbmh2U1lUWmFfMzFHaHhJY1Rhb2FmNWx6M3hwNW54YXQxeEZ3UFE1U1AyNy1JUVM4TTVLYVdEdGpkenJpaUZ1a2tyLUh6LWhMRGJjZVF5LUtVWmRPVTBVaXNKNXpTU2dNck5OaE1raVRYd1dwUXh4alRsemtURkZJc0VlUE1SdmpSYVpsZE16eXFuV3llaURzSVJ3MUtRYy1yYWFEaFJKZG42YndSbmhOV0U?oc=5","date":"2025-04-22","type":"pipeline","source":"PR Newswire","summary":"XADAGO/EQUFINA Set to Revolutionize Parkinson's Disease Treatment Landscape | DelveInsight - PR Newswire","headline":"XADAGO/EQUFINA Set to Revolutionize Parkinson's Disease Treatment Landscape | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxNZllSd2g1blhpVWJucGRwZ2ZFMTQ2Y2FPZ0E1NHppVzU5S1I0STBWZ1ZjblFxMXBXVHVXelhXTDF3OWd1MnlPR1ExMEFhYV9rbC02OUw3UjJRM1lJV2lyVUNORFFzR3NCZWxCeUVsYXdLTVR1UzIzQ1JQdnNvdGZaYVhqMHVOYWFSNFh5M3RXWVI4NlBRX0JKY29FbldKSUVoRk9XZU1VZXJQNFlfNjFBV2dORGVOQk9VUkdoS1JuQkd2SWcwX3RlbnUtZl9rbG9NZkNScFpGZkx6RzBGNEpsbjluQmlOejU2ZGhRSXpnS3Q0WUpQWTN2MGNUTkREbTUyQXJXdGJpY1I5YjV6N2VyenFLelZ2U2RzZ0RnSjEzQWlJbXNIRFhZcHREX0hweXNO?oc=5","date":"2024-12-12","type":"pipeline","source":"GlobeNewswire","summary":"Parkinson's Disease Market is Expected to Showcase a - GlobeNewswire","headline":"Parkinson's Disease Market is Expected to Showcase a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPcEZ3akphekFNenRhNHQ4LVJmWGVoaHRmRUlBYUVwb0VRSFBlQ2REa1JobGhaRGZYNmhKdDBueEdVUVQxTkhrSnRpNGtNbDdoVk1jTHJJSnFlVkZ6T2l3RGtsanpuVm5XWFNOQ250LWNDcGRPcmlZMWd5UW1WUHo5dzhJTnhBZnEtUHBaUEtJaXA2LWstc3ZZWUQ4LUtSRUxYQ01fN0xR?oc=5","date":"2024-12-10","type":"pipeline","source":"BioSpace","summary":"7 Most Promising Drugs in Parkinson’s Disease Treatment Pipeline - BioSpace","headline":"7 Most Promising Drugs in Parkinson’s Disease Treatment Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOeUZ6ZDROWXgzbVNOVWEwSXp4LTFBRUNVdTJ4Qy14T0Zjb1VYdzRTczZTMllmM0NlV1RaV3IwNVdpQkZVVmloNXM0Y011NlY3VFowUVVWMGhDLUFzSGY4TUUxTml3TU84aTJSQS0xWW53amU0N1hNWmF0UHJ4dzlMM1JFS1g3Q3dRTFFHX1hwNTJhMzhXeHc1VFRlVzMyUVlZV3hnNlBqb0JoTzU2bDVGUmRqUG8wT28?oc=5","date":"2017-10-25","type":"pipeline","source":"The Pharmaceutical Journal","summary":"Pre-reg exam pass rate below 50% for trainees from one pharmacy chain - The Pharmaceutical Journal","headline":"Pre-reg exam pass rate below 50% for trainees from one pharmacy chain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNSUJVVTM3WkxCVDR6NnpmTU1ubko0U1kxQjE0WFZUeVd4WUozTVdYQTgzbUh2ZE1wclVmazBuWWY5ajRpOXBtVjJNS1pQV0lTWTM1NnFwbWY0d3lGUE5VVXpOZ2NFeUp5REs4T1NneUhFRXlTc0t3UVkyZTl6eE1KVGZ2ZjhQemc2SFZGTVl6UEhmbFVLLVM4VTRKVGJkUQ?oc=5","date":"2017-01-22","type":"pipeline","source":"HR Grapevine","summary":"Britannia Pharmaceuticals hires Head of HR - HR Grapevine","headline":"Britannia Pharmaceuticals hires Head of HR","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOMlp2RWVOQkI4MHpWVEtYMEx5Qm9mZkE3Q2p2U25qS0xRMEdNTTJLeXhVdHpxbTBTTGpVc1pDMEJMc3JQend1M183dlVHeW5PVjFueFVfbUlaWGE4MUFmU192aGtyR3dad215MlFpOEx5RlNiWGdxVXBRZ294QzlKTG1Ibw?oc=5","date":"2013-05-03","type":"pipeline","source":"PMLiVE","summary":"Britannia promotes Robert Wood - PMLiVE","headline":"Britannia promotes Robert Wood","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}